Drugmaker Pfizer High On Sales

Pfizer Inc., the American multinational pharmaceutical and biotechnology corporation has seen its sales double in the fourth quarter.

With the global demand for the COVID-19 vaccine, the company continues to ride the wave in sales.

According to press reports, the company posted revenue of $23.8 billion, albeit missing analysts’ projections of $24.1 billion.

The company’s vaccine unit accounted for $13.9 billion, more than half of its total sales.

The company also reported a net income of $3.4 billion, topping analysts’ forecasts.

Pfizer said it expects $32 billion in sales this year from the COVID-19 vaccine, Comirnaty.

Readers Bureau, Contributor

Edited by Jesus Chan

Do you want to add feedback to this story?

Please add a comment in the box below or send an email to,  Call us at 201-500-7715 Support the Readers Bureau